Psychosocial Influences on Cancer Incidence and Progression

References

• Jensen A B. Psychosocial factors in breast cancer and their possible impact upon prognosis. Cancer Treat Rev 1991; 18: 191–210
   PubMed Web of Science ®Google Scholar
• Greer S, Morris T. Psychological attributes of women who develop breast cancer: a controlled study. J Psychosom Res 1975; 19: 147–53
   PubMed Web of Science ®Google Scholar
• Antoni M H, Goodkin K. Host moderator variables in the promotion of cervical neoplasia; I: personality facets. J Psychosom Res 1988; 32: 327–38
   PubMed Web of Science ®Google Scholar
• Lambley P. The role of psychological processes in the aetiology and treatment of cervical cancer: a biopsychological perspective. Br J Med Psychol 1993; 66: 43–60
   PubMedGoogle Scholar
• Bernhard J, Ganz P A. Psychosocial issues in lung cancer patients (part 1). Chest 1991; 99: 216–23
   PubMed Web of Science ®Google Scholar
• Kune G A, Kune S, Watson L F, Bahnson C B. Personality as a risk factor in large bowel cancer: data for the Melbourne Colorectal Cancer Study. Psychol Med 1991; 21: 43–60
   Google Scholar
• Hilakivi-Clarke L, Rowland J, Clarke R, Lippman M E. Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res Treat 1993; 29: 141–60
   Web of Science ®Google Scholar
• Cohen S, Wills T A. Stress, social support, and the buffering hypothesis. Psychol Bull 1985; 98: 310–57
   PubMed Web of Science ®Google Scholar
• Goodkin K, Antoni M H, Helder L, Sevin B. Psychoneuroimmunological aspects of disease progression among women with human papillomavirus-associated cervical dysplasia and human immunodeficiency virus type 1 co-infection. Int J Psychiatry Med 1993; 23: 119–48
   PubMed Web of Science ®Google Scholar
• Sarason I G, Levine H M, Basham R B, Sarason B R. Assessing social support: the Social Support Questionnaire. J Pers Soc Psychol 1983; 44: 127–39
   Web of Science ®Google Scholar
• Herbert T B, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med 1993; 55: 364–79
   PubMed Web of Science ®Google Scholar
• Holmes T H, Rahe R H. The Social Readjustment Rating Scale. J Psychosom Res 1967; 11: 213–8
   PubMed Web of Science ®Google Scholar
• Ewertz M. Bereavement and breast cancer. Br J Cancer 1986; 53: 701–3
   PubMed Web of Science ®Google Scholar
• Fournier D. Tumorwachstum als Kriterium der Malignität. Das Mammakarzinom, W Frommhold, P Gerhardt. Thieme, Stuttgart 1982
   Google Scholar
• Hatch M C, Wallenstein S, Beyea J, Nieves J W, Susser M. Cancer rates after the Three Mile Island nuclear accident and proximity of residence to the plant. Am J Public Health 1991; 81: 719–24
   PubMed Web of Science ®Google Scholar
• Forsén A. Psychosocial stress as a risk for breast cancer. Psychother Psychosom 1991; 55: 176–85
   PubMed Web of Science ®Google Scholar
• Geyer S. Life events prior to manifestation of breast cancer: a limited prospective study covering eight years before diagnosis. J Psychosom Res 1991; 35: 355–63
   PubMed Web of Science ®Google Scholar
• Brown G W, Harris T. The Bedford College Life-Events and Difficulty Schedule directory of contextual threat ratings of events. Bedford College, University of London, London 1978
   Google Scholar
• Shekelle R B, Raynor W J, Jr, Ostfeld A M, Garron D C, Bieliauskas L A, Liu S C, et al. Psychological depression and 17-year risk of death from cancer. Psychosom Med 1981; 43: 117–25
   PubMed Web of Science ®Google Scholar
• Persky V W, Kempthorne-Rawson J, Shekelle R B. Personality and risk of cancer: 20-year follow-up of Western Electric Study. Psychosom Med 1987; 49: 435–49
   PubMed Web of Science ®Google Scholar
• Fox B H. Depressive symptoms and risk of cancer [Editorial]. JAMA 1989; 262: 1231
   PubMed Web of Science ®Google Scholar
• Kaplan G A, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the Alameda County Study. J Behav Med 1988; 11: 1–13
   PubMed Web of Science ®Google Scholar
• Hahn R C, Petitti D B. Minnesota Multiphasic Personality Inventory-rated depression and the incidence of breast cancer. Cancer 1988; 61: 845–8
   PubMed Web of Science ®Google Scholar
• Zonderman A B, Costa P T, McCrae R R. Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA 1989; 262: 1191–5
   PubMed Web of Science ®Google Scholar
• Radloff L S. The CES-D Scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1977; 1: 385–401
   Web of Science ®Google Scholar
• Vogt T, Pope C, Mullooly J, Hollis J. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health 1994; 84: 227–31
   PubMed Web of Science ®Google Scholar
• Srole L, Langner T S, Michael S T. Mental health in the metropolis: the Midtown Manhattan Study. McGraw-Hill, New York 1962
   Google Scholar
• Hilakivi-Clarke L, Wright A, Lippman M E. DMBA-induced mammary tumor growth in rats exhibiting increased or decreased ability to cope with stress due to early postnatal handling or antidepressant treatment. Physiol Behav 1993; 54: 229–36
   Google Scholar
• Levenson J L, Bemis C. The role of psychological factors in cancer onset and progression. Psychosomatics 1991; 32: 124–32
   PubMed Web of Science ®Google Scholar
• Spiegel D, Sands S H. Psychological influences on metastatic disease progression. Metastasis/dissemination, E L Gorelik. Kluwer, DordrechtNetherlands 1989
   Google Scholar
• Derogatis L R, Abeloff M D, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA 1979; 242: 1504–8
   PubMed Web of Science ®Google Scholar
• Greer S, Morris T, Pettingale K W. Psychological response to breast cancer: effect on outcome. Lancet 1979; 2: 785–7
   PubMed Web of Science ®Google Scholar
• Greer S. Psychological response to cancer and survival. Psychol Med 1991; 21: 43–9
   PubMed Web of Science ®Google Scholar
• Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology, and tumor-host-response. Soc Sci Med 1985; 20: 833–40
   PubMed Web of Science ®Google Scholar
• Stavraky K M, Donner A P, Kincade J E, Stewart M A. The effect of psychosocial factors on lung cancer mortality at one year. J Clin Epidemiol 1988; 41: 75–82
   Google Scholar
• Stein S, Linn M W, Stein E M. Psychological correlates of survival in nursing home cancer patients. Gerontologist 1989; 29: 224–8
   PubMed Web of Science ®Google Scholar
• Parkes C M. Accuracy of predictions of survival in later stages of cancer. BMJ 1972; 2: 29–31
   PubMedGoogle Scholar
• Schwarz R, Geyer S. Social and psychological differences between cancer and noncancer patients: cause or consequence of the disease?. Psychother Psychosom 1984; 41: 195–9
   Google Scholar
• Kukull W A, McCorkle R, Driever M. Symptom distress, psychosocial variables, and survival from lung cancer. J Psychosoc Oncol 1986; 4: 29–41
   Google Scholar
• Weisman A D, Worden J W. The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med 1976–77; 7: 1–15
   PubMed Web of Science ®Google Scholar
• Dean C, Surtees P G. Do psychological factors predict survival in breast cancer?. J Psychosom Res 1989; 33: 561–9
   PubMed Web of Science ®Google Scholar
• Lazarus R S. The cost and benefits of denial. Stress and coping, A Monat, R S Lazarus. Columbia University Press, New York 1985; 154–73
   Google Scholar
• Kreitler S, Chaitchik S, Kreitler H. Repressiveness: cause or result of cancer?. Psycho Oncol 1993; 2: 43–54
   Google Scholar
• Berkman L F, Syme S L. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol 1979; 109: 186–204
   PubMed Web of Science ®Google Scholar
• House J S, Landis K R, Umberson D. Social relationships and health. Science 1988; 241: 540–5
   PubMed Web of Science ®Google Scholar
• Smith C E, Fernengel K, Holcroft C, Gerald K. Meta-analysis of the associations between social support and health outcomes. Ann Behav Med 1994; 16: 352–62
   Google Scholar
• Goodwin J S, Hunt W C, Key C R, Samet J M. The effect of marital status on stage, treatment and survival of cancer patients. JAMA 1987; 258: 3125–30
   PubMed Web of Science ®Google Scholar
• Reynolds P, Kaplan G A. Social connections and risk for cancer: prospective evidence from the Alameda County Study. Behav Med 1990; 16: 101–10
   PubMed Web of Science ®Google Scholar
• Ell K, Nishimoto R, Mediansky L, Mantell J, Hamovitch M. Social relations, social support and survival among patients with cancer. J Psychosom Res 1992; 36: 531–41
   PubMed Web of Science ®Google Scholar
• Hislop T G, Waxler N E, Coldman A J, Elwood J M, Kan L. The prognostic significance of psychosocial factors in women with breast cancer. J Chronic Dis 1987; 40: 729–35
   PubMedGoogle Scholar
• Waxler-Morrison N, Hislop T G, Mears B, Kan L. Effects of social relationships on survival for women with breast cancer: a prospective study. Soc Sci Med 1991; 33: 177–83
   PubMed Web of Science ®Google Scholar
• Maunsell E, Jacques B, Deschenes L. Social support and survival among women with breast cancer. Presented at the annual Psycho-oncology meeting, Memorial– Sloan Kettering Cancer Center. October, 1993
   Google Scholar
• Neale A V. Racial and marital status influences on 10 year survival from breast cancer. J Clin Epidemiol 1994; 47: 475–83
   PubMed Web of Science ®Google Scholar
• Levenson R W, Carstensen L L, Gottman J M. The influence of age and gender on affect, physiology, and their interrelations: a study of long-term marriages. J Pers Soc Psychol 1994; 67: 56–68
   PubMed Web of Science ®Google Scholar
• Levy S M, Herberman R B, Lippman M, D'Angelo R, Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 1991; 17: 67–75
   PubMed Web of Science ®Google Scholar
• Lazarus R S, Folkman S. Stress, appraisal, and coping. Springer, New York 1984
   Google Scholar
• Ramirez A J, Craig T K, Watson J P, Fentiman I S, North W R, Rubens R D. Stress and relapse of breast cancer. BMJ 1989; 298: 291–3
   PubMed Web of Science ®Google Scholar
• Barraclough J, Pinder P, Cruddas M, Osmond C, Taylor I, Perry M. Life events and breast cancer prognosis. BMJ 1992; 304: 1078–81
   PubMed Web of Science ®Google Scholar
• Stroebe M S, Stroebe W. The mortality of bereavement: a review. Handbook of bereavement: theory, research, and interventions, M S Stroebe, W Stroebe, R O Hansson. Cambridge University Press, New York 1993; 175–95
   Google Scholar
• Kaprio J, Koskenvuo M, Rita H. Mortality after bereavement: a prospective study of 95,647 widowed persons. Am J Public Health 1987; 77: 283–7
   PubMed Web of Science ®Google Scholar
• Jones D R, Goldblatt P O. Cause of death in widow(er)s and spouses. J Biosoc Sci 1987; 19: 107–21
   PubMed Web of Science ®Google Scholar
• Tornling G, Gustavsson P, Hogstedt C. Mortality and cancer incidence in Stockholm fire fighters. Am J Ind Med 1994; 25: 219–28
   PubMed Web of Science ®Google Scholar
• Spiegel D. Psychosocial intervention in cancer. J Natl Cancer Inst 1993; 85: 1198–205
   PubMed Web of Science ®Google Scholar
• Spiegel D, Bloom J R, Yalom I D. Group support for patients with metastatic cancer: a randomized prospective outcome study. Arch Gen Psychiatry 1981; 38: 527–33
   PubMed Web of Science ®Google Scholar
• Rosengren A, Tibblin G, Wilhelmsen L. Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. Am J Cardiol 1991; 68: 1171–5
   PubMed Web of Science ®Google Scholar
• Perissin L, Zorzet S, Rapozzi V, Paoletti D, Giraldi T. Seasonal dependency of the effects of experimental stressors on tumor metastasis on mice bearing Lewis lung carcinoma. Chronobiologia 1994; 21: 99–103
   Google Scholar
• Baltrusch H J, Stangel W, Titze I. Stress, cancer and immunity: new developments in biopsychosocial and psychoneuroimmunologic research. Acta Neurol 1991; 13: 315–27
   PubMedGoogle Scholar
• Hill D R, Kelleher K, Shumaker S A. Psychosocial interventions in adult patients with coronary heart disease and cancer: a literature review. Gen Hosp Psychiatry 1992; 14(6 suppl)28S–42S
   Google Scholar
• Spiegel D, Bloom J R, Kraemer H C, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888–901
   PubMed Web of Science ®Google Scholar
• Richardson J L, Shelton D R, Krailo M, Levine A M. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990; 8: 356–64
   PubMed Web of Science ®Google Scholar
• Fawzy F I, Fawzy N W, Hyun C S, Elashoff R, Guthrie D, Fahey J L, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681–9
   PubMed Web of Science ®Google Scholar
• Gellert G A, Maxwell R M, Siegel B S. Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-year follow-up study. J Clin Oncol 1993; 11: 66–9
   PubMed Web of Science ®Google Scholar
• Morgenstern H, Gellert G A, Walter S D, Ostfeld A M, Siegel B S. The impact of a psychosocial support program on survival with breast cancer: the importance of selection bias in program evaluation. J Chronic Dis 1984; 37: 273–82
   PubMedGoogle Scholar
• Ilnyckyj A, Farber J, Cheang M C, Weinerman B. An 11 yr follow up of a randomized study of support groups (gps) in cancer patients (pts) [Abstract]. Clin Invest Med 1993; 16(4 suppl)B95
   Google Scholar
• Grossarth-Maticek R, Eysenck H J. Creative novation behaviour therapy as a prophylactic treatment for cancer and coronary heart disease; part I: description of treatment. Behav Res Ther 1991; 29: 1–16
   PubMedGoogle Scholar
• Grossarth-Maticek R, Schmidt P, Vetter H, Arundt S. Psychotherapy research in oncology. Health care and human behavior, A Steptoe, A Mathews. Academic, London 1984; 325–41
   Google Scholar
• Eysenck H J, Grossarth-Maticek R. Creative novation behaviour therapy as a prophylactic treatment for cancer and coronary heart disease; part II: effects of treatment. Behav Res Ther 1991; 29: 17–31
   PubMed Web of Science ®Google Scholar
• Fox B H. Quandaries created by unlikely numbers in some of Grossarth-Maticek's studies. Psychol Inquiry 1991; 2: 242–7
   Google Scholar
• Van der Ploeg H M. What a wonderful world it would be: a reanalysis of some of the work of Grossarth-Maticek. Psychol Inquiry 1991; 2: 280–5
   Google Scholar
• Mulder C L, Van der Pompe G, Spiegel D, Antoni M H, De Vries M J. Do psychosocial factors influence the course of breast cancer: a review of recent literature, methodological problems and future directions. Psycho Oncol 1992; 1: 155–67
   Google Scholar
• Stones M J, Dornan B, Kozma A. The prediction of mortality in elderly institution residents. J Gerontol 1989; 44: 72–9
   PubMedGoogle Scholar
• Andersen B L, Kiecolt-Glaser J K, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol 1994; 49: 389–404
   PubMed Web of Science ®Google Scholar
• Butrum R P, Clifford C K, Lanza E. NCI dietary guideline: rationale. Am J Clin Nutr 1988; 48: 888–95
   PubMed Web of Science ®Google Scholar
• Klaish L A. Relationship of body size with breast cancer. J Clin Oncol 1984; 2: 287–93
   Google Scholar
• Albanes D. Total calories, body weight, and tumor incidence in mice. Cancer Res 1987; 47: 1987–92
   PubMed Web of Science ®Google Scholar
• Eberlein T, Simon R, Fisher S, Lippman M. Height, weight and risk of breast cancer relapse. Breast Cancer Res Treat 1985; 5: 81–6
   PubMedGoogle Scholar
• Zumoff B, Gorzynski J G, Katz J L, Weiner H, Levin J, Holland J, et al. Nonobesity at the time of mastectomy is highly predictive of 10-year disease-free survival in women with breast cancer. Anticancer Res 1982; 2: 59–62
   PubMedGoogle Scholar
• Garland M, Willett W C, Manson J E, Hunter D J. Antioxidant micronutrients and breast cancer. J Am Coll Nutr 1993; 12: 400–11
   PubMed Web of Science ®Google Scholar
• Schatzkin A, Longnecker M P. Where are we now and where do we go from here?. Cancer 1994; 74: 1101–10
   PubMed Web of Science ®Google Scholar
• Yirmiya R, Ben-Eliyahu S, Gale R P, Shavit Y, Liebeskind J C, Taylor A N. Ethanol increases tumor progression in rats; possible involvement of natural killer cells. Brain Behav Immun 1992; 6: 74–86
   PubMed Web of Science ®Google Scholar
• Bagenal F S, Easton D F, Harris E, Chilvers C E, McElwain T J. Survival of patients with breast cancer attending Bristol Cancer Help Center. Lancet 1990; 336: 606–10
   PubMed Web of Science ®Google Scholar
• Hodgson L A. Why do we need sleep? Relating theory to nursing practice. J Adv Nurs 1991; 16: 1503–10
   PubMed Web of Science ®Google Scholar
• Strang P, Qvarner H. Cancer-related pain and its influence on quality of life. Anticancer Res 1990; 10: 109–12
   PubMed Web of Science ®Google Scholar
• Silberfarb P M, Hauri P J, Oxman T E, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 1993; 11: 997–1004
   PubMed Web of Science ®Google Scholar
• Everson C A. Sustained sleep deprivation impairs host defense. Am J Physiol 1993; 265: 1148–54
   PubMedGoogle Scholar
• Itano J, Tanabe P, Lum J, Lamkin L, Rizzo E, Weiland M, et al. Compliance and noncompliance in cancer patients. Prog Clin Biol Res 1983; 120: 483–95
   Google Scholar
• Glass A, Wieand H S, Fisher B, Redmond C, Lerner H, Wolter J, et al. Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. Cancer Treat Rep 1981; 65: 363–76
   PubMedGoogle Scholar
• Laszlo J, Lucas V S, Huang R. Emesis as a critical problem in chemotherapy. N Engl J Med 1981; 305: 948–9
   PubMed Web of Science ®Google Scholar
• Lee Y T. Adjuvant chemotherapy (CMF) for breast carcinoma: patient's compliance and total dose achieved. Am J Clin Oncol 1983; 6: 25–30
   Google Scholar
• Wilcox P M, Fetting J F, Nettesheim K M, Abeloff M D. Anticipating vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 1982; 66: 1601–4
   PubMedGoogle Scholar
• Marcus A C, Crane L A, Kaplan C P, Reading A E, Savage E, Gunning J, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care 1992; 30: 216–30
   PubMed Web of Science ®Google Scholar
• Lerman C, Miller S M, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991; 165: 658–62
   PubMed Web of Science ®Google Scholar
• Hoagland A C, Morrow G R, Bennett J M, Carnrike C L, Jr. Oncologists' views of cancer patient noncompliance. Am J Clin Oncol 1983; 6: 239–44
   PubMedGoogle Scholar
• Steckel S B. Predicting, measuring, implementing and following up on patient compliance. Nurs Clin North Am 1982; 17: 491–8
   Google Scholar
• Lerman C, Hanjani P, Caputo C, Miller S, Delmoor E, Nolte S, et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992; 10: 330–3
   PubMed Web of Science ®Google Scholar
• Given B A, Given C W. Compliance among patients with cancer. Oncol Nurs Forum 1989; 16: 97–103
   PubMedGoogle Scholar
• Lerman C, Rimer B, Blumberg B, Cristinzio S, Engstrom P F, MacElwee N, et al. Effects of coping style and relaxation on cancer chemotherapy side effects and emotional responses. Cancer Nurs 1990; 13: 308–15
   PubMed Web of Science ®Google Scholar
• Ley P. The psychology of compliance. Research in psychology and medicine, D J Osborne, M M Gruenberg, J R Eiser. Academic, London 1979; vol 2: 187–95
   Google Scholar
• Bandura A. Self-efficacy: toward a unifying theory of behavior change. Psychol Rev 1977; 84: 191–215
   PubMed Web of Science ®Google Scholar
• Ferguson K, Bole G G. Family support, health beliefs, and therapeutic compliance in patients with rheumatoid arthritis. Patient Couns Health Educ 1979; 1: 101–5
   PubMedGoogle Scholar
• Beck N C, Parker J C, Frank R G, Geden E A, Kay D R, Gamache M, et al. Patients with rheumatoid arthritis at high risk for noncompliance with salicylate treatment regimens. J Rheumatol 1988; 15: 1081–4
   Google Scholar
• Taylor S E, Lichtman R R, Wood J V. Attributions, beliefs about control, and adjustment to breast cancer. J Pers Soc Psychol 1984; 46: 489–502
   PubMed Web of Science ®Google Scholar
• Wyszynski A A. Managing noncompliance in the ‘difficult’ medical patient. Psychother Psychosom 1990; 54: 181–6
   Google Scholar
• Rose R M. Overview of endocrinology of stress. Neuroendocrinology and psychiatric disorder, G M Brown, S H Koslow, S Reichlin. Raven, New York 1984; 95–122
   Google Scholar
• McDaniel J S, Musselman D L, Porter M R, Reed D A, Nemeroff C B. Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 1995; 52: 89–99
   PubMed Web of Science ®Google Scholar
• Chrousos G P, Gold P W. The concepts of stress and stress system disorder. JAMA 1992; 267: 1244–52
   PubMed Web of Science ®Google Scholar
• Nemeroff C B, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226: 1342–4
   PubMed Web of Science ®Google Scholar
• Sapolsky R M, Krey L C, McEwen B S. The adrenocortical axis in the aged rat: impaired sensitivity to both fast and delayed feedback inhibition. Neurobiol Aging 1986; 7: 331–5
   PubMed Web of Science ®Google Scholar
• Sapolsky R M, Donnelly T M. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 1985; 117: 662–5
   PubMedGoogle Scholar
• Folkman J, Langer R, Linhardt R, Haudenschild C, Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 1983; 221: 719–25
   PubMed Web of Science ®Google Scholar
• Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981; 212: 1100–9
   PubMed Web of Science ®Google Scholar
• Rowse G J, Weinberg J, Bellward G D, Emerman J T. Endocrine mediation of psychosocial stressor effects on mouse mammary tumor growth. Cancer Lett 1992; 65: 85–93
   Google Scholar
• Godden J, Leake R, Kerr D J. The response of breast cancer cells to steroid and peptide growth factors. Anticancer Res 1992; 12: 1683–8
   Google Scholar
• Malarkey W B, Kennedy M, Allred L E, Milo G. Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. J Clin Endocrinol Metab 1983; 56: 673–7
   Google Scholar
• Shafie S, Brooks S C. Effect of prolactin on growth and the estrogen receptor level of human breast cancer (MCF-7). Cancer Res 1977; 37: 792–9
   PubMed Web of Science ®Google Scholar
• Sternberg E M, Wilder R L, Gold P W, Chrousos G P. A defect in the central component of the immune system–hypothalamic-pituitary-adrenal axis feedback loop is associated with susceptibility to experimental arthritis and other inflammatory diseases. Ann N Y Acad Sci 1990; 594: 289–92
   PubMed Web of Science ®Google Scholar
• Felten S Y, Olschowka J. Noradrenergic sympathetic innervation of the spleen: tyrosine hydroxylase (TH)-positive nerve terminals from synaptic-like contacts on lymphocytes in the splenic white pulp. J Neurosci Res 1987; 18: 37–48
   PubMed Web of Science ®Google Scholar
• Drucker D, McLaughlin J. Adrenocortical dysfunction in acute medical illness. Crit Care Med 1986; 14: 789–91
   PubMedGoogle Scholar
• Parker L N, Levin E R, Lifrak E T. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985; 60: 947–52
   PubMed Web of Science ®Google Scholar
• Ozasa H, Kita M, Inoue T, Mori T. Plasma dehydroepiandrosterone-to-cortisol ratios as an indicator of stress in gynecologic patients. Gynecol Oncol 1990; 37: 178–82
   PubMed Web of Science ®Google Scholar
• Bulbrook R D, Hayward J L. Abnormal urinary steroid excretion and subsequent breast cancer: a prospective study in the Island of Guernsey. Lancet 1967; 1: 519–22
   Google Scholar
• Irwin M, Daniels M, Risch S C, Bloom E, Weiner H. Plasma cortisol and natural killer cell activity during bereavement. Biol Psychiatry 1988; 24: 173–8
   PubMed Web of Science ®Google Scholar
• Cohen S, Tyrrell D A, Smith P A. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325: 606–12
   PubMed Web of Science ®Google Scholar
• Levine S, Coe C, Weiner S G. Psychoneuroendocrinology of stress: a psychobiological perspective. Psychoendocrinology, F R Brush, S Levine. Academic, San Diego 1989; 341–77
   Google Scholar
• Ader R, Felten D, Cohen N. Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 1990; 30: 561–602
   PubMed Web of Science ®Google Scholar
• Romano T A, Felten S Y, Felten D L, Olschowka J A. Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav Immun 1991; 5: 116–31
   PubMedGoogle Scholar
• Madden K S, Felten S Y, Felten D L, Sundaresan P R, Livnat S. Sympathetic neural modulation of the immune system; I: depression of T cell immunity in vivo and in vitro following chemical sympathectomy. Brain Behav Immun 1989; 3: 72–89
   PubMedGoogle Scholar
• Lorton D, Bellinger D L, Felten S Y, Felten D L. Substance P innervation of spleen in rats: nerve fibers associate with lymphocytes and macrophages in specific compartments of the spleen. Brain Behav Immun 1991; 5: 29–40
   PubMedGoogle Scholar
• Strauman T J. Self-discrepancies in clinical depression and social phobia: cognitive structures that underlie emotional disorders?. J Abnorm Psychol 1989; 98: 5–14
   Google Scholar
• Strauman T J, Lemieux A M, Coe C L. Self-discrepancy and natural killer cell activity: immunological consequences of negative self-evaluation. J Pers Soc Psychol 1993; 64: 1042–52
   PubMed Web of Science ®Google Scholar
• Bovbjerg D H, Redd W H, Maier L A, Holland J C, Lesko L M, Niedzwiecki D, et al. Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer. J Consult Clin Psychol 1990; 58: 153–7
   PubMed Web of Science ®Google Scholar
• Villa M L, Ferrario E, Bergamasco E, Bozzetti F, Cozzaglio L, Clerici E. Reduced natural killer cell activity and IL-2 production in malnourished cancer patients. Br J Cancer 1991; 63: 1010–4
   PubMed Web of Science ®Google Scholar
• Bovbjerg D. Psychoneuroimmunology and cancer. Handbook of psychooncology: psychological care of the patient with cancer, J C Holland, J H Rowland. Oxford University Press, New York 1989; 727–54
   Google Scholar
• Rosenberg S, Lotze M. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Annu Rev Immunol 1986; 4: 681–709
   PubMed Web of Science ®Google Scholar
• Herberman R. Natural killer (NK) cells: characteristics and possible role in resistance against tumor growth. Immunity to cancer, A E Reif, M S Mitchell. Academic, Orlando 1985; 217–29
   Google Scholar
• Levy S M, Herberman R B, Whiteside T, Sanzo K, Lee J, Kirkwood J. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med 1990; 52: 73–85
   PubMed Web of Science ®Google Scholar
• Fawzy F I, Kemeny M E, Fawzy N W, Elashoff R, Morton D, Cousins N, et al. A structured psychiatric intervention for cancer patients; II: changes over time in immunological measures. Arch Gen Psychiatry 1990; 47: 729–35
   PubMed Web of Science ®Google Scholar
• Zanker K S, Kroczek R. Looking along the track of the psychoneuroimmunologic axis for missing links in cancer progression. Int J Sports Med 1991; 12(suppl 1)S58–62
   Google Scholar
• Shavit Y, Terman G W, Martin F C. Stress, opioid peptides, the immune system, and cancer. J Immunol 1985; 135(2 suppl)834s–7s
   Google Scholar
• Ben-Eliyahu S, Yirmiya R, Liebeskind J C, Taylor A N, Gale R P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 1991; 5: 193–205
   PubMedGoogle Scholar
• Stutman O. Immunological surveillance revisited. Immunity to cancer, A E Reif, M S Mitchell. Academic, Orlando 1985; 323–45
   Google Scholar
• Doll R, Kinlen L. Immunosurveillance and cancer: epidemiological evidence. BMJ 1970; 4: 420–2
   PubMed Web of Science ®Google Scholar
• Kennedy S, Kiecolt-Glaser J K, Glaser R. Immunological consequences of acute and chronic stressors: mediating role of interpersonal relationships. Br J Med Psychol 1988; 61: 77–85
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J K, Fisher L, Ogrocki P, Stout J C, Speicher C E, Glaser R. Marital quality, marital disruption, and immune function. Psychosom Med 1987; 49: 13–34
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J K, Kennedy S, Malkoff S, Fisher L, Speicher C E, Glaser R. Marital discord and immunity in males. Psychosom Med 1988; 50: 213–29
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J K, Garner W, Speicher C, Penn G M, Holliday J, Glaser R. Psychosocial modifiers of immunocompetence in medical students. Psychosom Med 1984; 46: 7–14
   PubMed Web of Science ®Google Scholar
• Pennebaker J W, Kiecolt-Glaser J K, Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol 1988; 56: 23–45
   Google Scholar
• Lechin F, Van der Dijs B, Vitelli-Florez G, Lechin-Baez S, Azocar J, Cabrera A, et al. Psychoneuroendocrinological and immunological parameters in cancer patients: involvement of stress and depression. Psychoneuroendocrinology 1990; 15: 435–51
   PubMed Web of Science ®Google Scholar